Drug Profile
Insulin intranasal - West Pharmaceutical Services
Alternative Names: Insulin nasal - West Pharmaceutical ServicesLatest Information Update: 01 Feb 2008
Price :
$50
*
At a glance
- Originator West Pharmaceutical Services Drug Delivery and Clinical Research Centre
- Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 24 Jul 2013 Biomarkers information updated
- 14 May 2003 No development reported - Phase-II for Diabetes mellitus in United Kingdom (Intranasal)
- 26 Jan 2001 DanBioSyst is now called West Pharmaceutical Services Drug Delivery and Clinical Research Centre